Publication | Open Access

Clinical Outcomes and Risk Stratification in Patients With Metastatic Hormone-Sensitive Prostate Cancer Treated With New-Generation Androgen Receptor Signaling Inhibitors

UrologyGenitourinary CancerMedicineCancer ManagementNew-generation Androgen ReceptorClinical OutcomesProstatic DiseaseOncologyRadiation OncologyRisk StratificationEndocrine-related CancerHealth Sciences